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Abstract
Skin scarification (s.s.) with Vaccinia virus (VACV) is essential for generation of an optimal
protective T cell memory immune response. Dendritic Cells (DC), which are professional antigen
presenting cells, are required for naïve T cell priming and activation. At least three subsets of skin
resident DC have been identified: Langerhans Cells (LC), Dermal Langerin+ DC (Lang+dDC) and
Dermal Langerin− DC (Lang−dDC). Using Langerin-diphtheria toxin receptor mice and
established mouse model of VACV delivered by s.s., we demonstrated that Lang+dDC, but not
LC, are absolutely required for the induction of a rapid and robust antigen-specific CD8+ T cell
response after s.s. with VACV. The depletion of Lang+dDC led to a significant delay in the
priming and proliferation of antigen-specific CD8+ T cells. Moreover CD8+ T cells generated after
VACV s.s. in the absence of Lang+dDC lacked effector cytotoxic functions both in vitro and in
vivo. While s.s.-immunized WT and LC depleted mice controlled the progression of OVA257–264
expressing T cell lymphoma EG7 (injected intradermally), the depletion of Lang+dDC led to rapid
lymphoma progression and mortality. These data indicate that of all skin DC subsets, Lang+dDC
the most critical for the generation of robust CD8+ T cell immunity after s.s. with VACV.
Introductory Paragraph
Vaccinia virus (VACV) immunization provides complete protection against Variola major,
the causative agent of smallpox, and a vaccination campaign based on this strategy led to the
worldwide eradication of smallpox disease (Hammarlund et al., 2003; Stewart and Devlin,
2006). We have observed that protection against VACV is more closely associated with a
protective T cell immune response, rather than neutralizing antibody production (Liu et al.,
2010). More specifically, CD8+ T cells, many of them tissue resident memory cells (TRM)
play a pivotal role in controlling VACV infections(Jiang et al., 2012). In mice and human,
immunization with VACV results in an acute infection that elicits strong and efficient
development of cytotoxic CD8+ T cells response. Moreover we have previously shown that
the mode of vaccine delivery is very important in the induction of a robust immune response
against VACV. We have demonstrated that immunization through the skin via skin
scarification (s.s.), rather than conventional vaccine injection routes as subcutaneous (s.c.) or
intramuscular (i.m.), is most effective for the generation of the strong T cell mediated
immune response (Liu et al., 2010).
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tT cell priming, activation and proliferation are dependent upon professional antigen
presenting cells such as dendritic cells (DC). In mice, blood-derived conventional DC can be
divided in two subsets: CD8α+ DC and CD8α− DC. The CD8α− DC were then classified
into CD4+ and CD4−DC populations (Heath and Carbone, 2009; Vremec et al., 2000). The
lymph nodes contain also a subset of migrating DC. In skin draining lymph nodes (LN),
three subsets of migrating DC can be defined: Langerhans cells (LC), dermal Langerin+ DC
(Lang+dDC), and dermal Langerin− DC (Lang−dDC) (Bursch et al., 2007; Ginhoux et al.,
2007; Poulin et al., 2007). It is now clear that in mice models, LC are unable to generate
CD8+ T cell immunity to viral infection, especially to herpes simplex virus type 1 (HSV-1)
after infection of the skin epidermis (Allan et al., 2003; Bedoui et al., 2009). Moreover, in
constitutive and inducible LC deficient mice models, LC appeared to be largely dispensable
for contact hypersensitivity sensitization, and may actually generate tolerance and dampen
inflammation (Bobr et al., 2010; Igyarto et al., 2009; Kaplan et al., 2005). Since the
discovery of bone marrow derived skin Lang+dDC, extensive studies evaluated the role of
this DC subset for antigen presentation and for the generation of immune response during
infection or inflammation. It has been suggested that Lang+dDC contribute to immune
responses against HSV (Bedoui et al., 2009), leishmania major (Brewig et al., 2009), or
those generated after contact hypersensitivity reactions (Kaplan et al., 2008). However, the
relative role of these subsets of skin resident DC in the induction of immune response after
s.s. with VACV remains unknown.
In this study, we investigated the role of LC and Lang+dDC in cross-priming responses to
VACV inoculated by s.s. in transgenic mice expressing the Diphtheria toxin receptor under
the control of the murine Langerin promoter (Lang-DTR) mouse model (Kissenpfennig et
al., 2005). As shown previously, the systemic administration of DT depletes LC, and
repopulation is delayed for several weeks, whereas Lang+dDC are replenished within a few
days. Taking advantage of this model, we selectively depleted either LC alone or both LC
and Lang+DC. Then, using recombinant VACV that expressed the ovalbumin peptide
OVA257–264 (rVACV-ova) and adoptive transfer of OVA257–264-specific CD8+ T cells from
OT-I TCR transgenic mice, we demonstrated that Lang+dDC are required for the induction
of a rapid and robust antigen-specific CD8+ T cells immunity after s.s. against VV. The
depletion of LC alone had no discernable effect on immunity after s.s. However, the
depletion of Lang+DC as well led to a significant delay in the priming and proliferation of
antigen-specific CD8+ T cells. Moreover, CD8+ T cells generated after VACV s.s. in the
absence of Lang+dDC lacked effector cytotoxic functions both in in vitro and in vivo. While
s.s.-immunized WT and LC depleted mice control the progression of the OVA257–264
expressing T cell lymphoma EG7 (injected intradermally), the depletion of Lang+dDC led to
more rapid lymphoma progression and mortality. These data suggest of all skin DC subsets,
only Lang+dDC are critical for the generation of robust protective CD8+ T cell immunity
after s.s. with VACV.
RESULTS
Lang+dDC are required for efficient activation and proliferation of antigen-specific CD8+ T
cells in draining LN after VACV immunization via s.s
To compare the activation and proliferation of antigen-specific CD8+ T cells after VACV
immunization via s.s., we first treated lang-DTR mice with systemic DT 13 days before
immunization (LC depleted group) or 13 days, 1 day before immunization and then every
48h (Lang +DC depleted group). WT C57Bl/6 recipient mice were also treated with
systemic administration of DT as a control (Figure 1a). As shown in Supplementary Figure
S1, Lang+DC are not affected by DT injection in WT mice. After one single injection of DT
13 days before immunization, LC are still absent of the epidermis and Lang+dDC are
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treplenished but at a lower level compared to WT group, while Lang+DC are totally absent
when DT injection is injected 13 days and 1 day before immunization. We then adoptively
transferred carboxy-fluorescein diacetate succinimidyl ester (CFSE) labeled Th1.1+ naïve
CD8+ T cells isolated from OT-I T cell receptor (TCR) transgenic mice 24h prior rVACV-
ova immunization via s.s. At day 3, 5 and 7, skin draining inguinal lymph nodes (ILN), were
harvested and analyzed for OT-I cell proliferation (Figure 1b). As previously shown(Liu et
al., 2006), high proliferation of OT-I harvested from WT mice group was detected in ILN
that drained the scarified infected site. In LC depleted group, proliferation of OT-I cells was
comparable to WT, while in Lang+DC depleted group, proliferation of OT-I mice was
significantly reduced at day 3, 5 and 7. However, some activated OT-I cells were detected at
day 7 in ILN from Lang +DC depleted mice group. Moreover, no significant proliferation
were found in LN draining others tissues in all mice groups, although a small number of
dividing OT-I cells were also found in spleen in control group (Supplementary Figure S2).
These data suggest that Lang+dDC are required for a rapid and robust priming and
proliferation of antigen-specific CD8+ T cells in skin draining lymph nodes after s.s.
immunization against VACV. In additional experiments, to analyze the capacity to cross-
present rVACV-ova of each subsets of DC early after immunization, we used a sorting
scheme of DC previously described(Henri et al., 2010), allowing the isolation of populations
of CD207 (EGFP)+ CD103+ dDC, CD207 (EGFP)+ CD103− fraction that comprises the
majority of mLCs and a small fraction of CD207 (EGFP)+ CD103− dDC and CD207
(EGFP)− CD103− DC and LN resident DC in cutaneous LN, 48h after immunization with
rVACV-ova. As shown in Supplementary Figuer S3, each subset were then incubated in
vitro with purified CFSE-labeled OT-I cells and OT-I proliferation was then assessed by
flow cytometry, showing that CD207(EGFP)+ CD103+ dDC were the major DC population
capable of cross-presentation, in an early phase of immunization compared to others skin
DC populations showing minimal or absence of ability for cross-presentation.
The absence of Lang+DC delays and reduces the infiltration of antigen-specific CD8+ T
cells in infected skin
Having shown that Lang+dDC are required for early activation and proliferation of antigen-
specific CD8+ T cells in skin draining LN after s.s. infection with VACV, we asked whether
the absence of Lang+dDC can also affect the infiltration of T cells in infected skin at
different time point (days 3 and 7). Skin s.s. infected tails from WT group, LC depleted
group and Lang+DC depleted group, were harvested. T cells were extracted from tail skin
and analyzed by flow cytometry. Activated OT-I cells were significantly reduced in
Lang+DC depleted group when compared to WT and LC depleted group (Figure 2a,b). We
next analyzed the expression of homing molecules: E- and P-Lig on T cells using E selectin/
Fc or P selectin/Fc chimeric molecules, on OT-I cells in ILN after s.s. In both WT and the
LC depleted group proliferating OT-I cells showed an upregulation of skin-homing
molecules in ILN of s.s. infected mice (Figure 2c,d). In the absence of Lang+DC, the
activation and proliferation of OT-I cells decreased dramatically, but the small fraction of T
cells undergoing proliferation in the Lang+DC depleted group expressed E- and P-Lig at the
same level than WT and LC depleted groups. Altogether our data demonstrate that
Lang+dDC are required for the effective early activation and proliferation of antigen-specific
T cells in skin draining LN after immunization via s.s., they do not appear to affect the
expression of skin homing receptors once antigen-specific CD8+ T cells become activated.
In the absence of Lang+dDC, OT-I cells do not acquire effector functions
Having shown that absence of Lang+dDC decreases and delays the activation and
proliferation of antigen-specific CD8+ T cells after immunization via s.s., we wished to
determine whether OT-I cells could acquire effector functions despite of the depletion of
Lang+dDC. WT mice group (DT -13,-1 and every 48h), LC depleted group (DT-13) and
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tLang+DC depleted group (DT-13,-1 and every 48h) were immunized with rVACV-ova via
s.s. 1 day after adoptive transfer of CFSE labeled OT-I cells. On day 3 and 7 after
immunization, skin draining ILN and spleen cells were harvested and re-stimulated in vitro
with 1µM OVA257–264 in the presence of Brefeldin. IFNγ production was then analyzed
using flow cytometry. Proliferating OT-I T cells in WT and LC depleted group produced
high amount of IFNγ in skin draining ILN and spleen at day 3 and 7. In contrast, in the
absence of Lang+DC, the percentage of OT-I producing IFNγ was significantly reduced in
the early phase of T cells activation in contrast to latter activation. (Figure 3a,b).
CD8+ T cells effector functions are not only measured by the production of IFNγ, but also
by their cytotoxic activity in vitro. In order to test this function, we set up a cytolysis assay.
Mice from the WT group, LC depleted group and Lang+DC depleted group were immunized
with rVACV-ova after adoptive transfer of OT-I cells. On day 5, OT-I cells from skin
draining ILN were harvested by positive selection. EG7 cells were used as target cells.
Target cells were labeled with PKH-26 according to the manufacturer’s instructions and
then with CFSE and dispensed into plates. OT-I cells isolated from lymph node at day 5
after s.s.-immunization, were added at different ratios and mixed with target cells for 5h
before analysis. In vitro generated effector OT-I cells and naïve OT-I cells were used as
positive and negative control respectively. After 5h of incubation, dilution of CFSE on
PKH-26+ target cells was analyzed by flow cytometry. Cytotoxic activity was lower in the
presence of OT-I isolated from Lang+DC depleted group whereas cytotoxic activity was
high in the presence of OT-I harvested from WT and LC depleted groups (Figure 4). These
data suggest that Lang+dDC are required for the induction of a strong effector cytotoxic
CD8+ T cell immune response after immunization via s.s.
Lang+dDC modulate tumor immunity induced by immunization via s.s
Our data demonstrate that Lang+dDC modulate the development of the strong effector/
cytotoxic CD8+ T cells immune response against VACV after s.s. that we have observed
previously (Jiang et al, 2012). Our previous study showed that immunization with VACV
via s.s. is more effective than other routes of immunization to protect mice against tumor
challenge (Liu et al., 2010). We asked whether Lang+dDC could impair the effective
protection of s.s. route in terms of tumor protection. WT group, LC depleted (DT-13) and
Lang+DC depleted group (DT-13,-1, every 72h) were immunized with rVV-ova via s.s. and
then challenged with EG7 tumor cells intradermally on the same day. In WT mice, tumors
became palpable 5–8 days after challenge in the untreated group, and subsequent tumor
growth was rapid (Figure 5 a,b). In WT mice immunized with VACV-ova, tumor growth
was significantly retarded and was negligible even at 25 days. The LC depleted group
showed results indistinguishable from the WT group. In contrast, Lang+DC depleted group
developed early palpable tumors which, over time, grew to a large size at day 18
(Supplementary Figure S4) and which grew rapidly thereafter and experienced rapid
mortality (Supplementary Figure S5). Thus, all immunized mice developed some tumor
immunity, althoughdepleted of both LC and Lang+dDC developed tumor immunity that was
less robust. These data indicate that Lang+dDC represent a subset of DC important for an
efficient tumor immune response after s.s. immunization, but also suggest that other Lang-
DC play a significant role in tumor immunity.
DISCUSSION
Immunization through the skin using VACV delivered by s.s. effectively eradicated Variola
major infection worldwide. We have recently observed that this remarkable efficacy was
more closely associated with the delivery mode of immunization using superficially injured
skin (i.e., s.s.), rather than immunogenicity of the virus per se (Liu et al., 2010). We have
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tdemonstrated that immunization via s.s. using VACV is highly effective to induce antigen-
specific T cell response, protecting mice against VACV infection independently of
neutralizing antibody production. Moreover, mice previously immunized via s.s. with a
recombinant VV loaded with tumor antigen were better protected against tumor challenge in
skin than mice immunized via conventional routes. However, the precise mechanism by
which immunization through epidermis is so remarkably effective remains unknown. The
present study rules out epidermal LC as contributing to this efficacy. Immunization using
skin disruption mobilizes a large number of skin resident DC (Romani et al., 2010; Sparber
et al., 2010; Steinman, 2008). Migrating DC to skin draining LN are required to prime the
specific T cell immune response. It is now well accepted that poxvirus infection through
skin scarification results in a response highly dependent on cross-presentation(Shen et al.,
2002) and our present data suggest that a specific subset of skin resident DC, the Lang+dDC
are required for the induction of an early activation and proliferation of antigen specific
effector CD8 T cell after VACV immunization through the skin. Cross-priming has been
studied in systems where DC are not theirself infected. In the case of VACV, infection of
DC can occur but is known to be abortive, leading to expression of a subset of early genes
but absolutely no late viral genes, particularly ones required to viral assembly and
replication (Chahroudi et al., 2006; Jenne et al., 2000). Infected DC are subject to apoptosis,
supporting an immune response against VACV through cross-presentation of exogenous
viral antigens acquired by uninfected DC from dying cells, as well as from ambient late gene
products released by apoptotic keratinocytes. Moreover It has been recently shown in a
mouse model of VACV infection that cross-priming of virus specific T cells was mediated
through the expression of a DC-restricted receptor DNGR-1(Iborra et al., 2012).
Mouse skin resident DC subpopulations consist at least of three different DC subsets: LC,
Lang−dDC and the Lang+dDC. Lang+dDC were recently discovered in 2007 as a Lang+DC
population distinct from LC (Bursch et al., 2007; Ginhoux et al., 2007; Poulin et al., 2007).
Since this time, research focused to define the role of these different skin resident DC
subpopulations in the generation of immune response.
In our present study, we combined the advantages of two different models: the murine
VACV vaccination model developed in our laboratory(Liu et al., 2006) and the lang-DTR
mice allowing the selective depletion of LC and/or Lang+DC, in order to define the precise
role of resident skin DC in the induction of the early phase of T cell immune response after
VACV immunization. We first observed that the depletion of Lang+dDC inhibited the early
activation and proliferation of antigen-specific CD8+ T cell in the skin draining LN and
Lang+dDC appear as the only DC population to cross-present virus in the early phase of
immunization. Moreover, in the absence of Lang+dDC, the generation of CD8+ T cell
effector function was also impaired as measured by production of IFNγ and in their
functional in vitro cytotoxic activity. These data are consistent with findings observed in the
literature for other antigens. Recently, after subcutaneous infection with leishmania major,
Lang+ non-LC were found to be the major subset of skin migratory DC to induce CD8+ T
cell activation (Brewig et al., 2009). Later studies using HSV-1 model have found that
Lang+dDC contribute to the generation of HSV-1-specific CTL immunity during the second
phase of HSV infection (Bedoui et al., 2009). However, in our present study, we still
observed a late activation and proliferation of antigen-specific T cells despite the total
absence of Lang+DC. It is well documented that the LN resident CD8α+ DC can also play
an active role in CD8+ T immunity. LN resident CD8α+ DC can capture antigen from
migratory DC or from material draining directly through the lymphatic conduits (Heath and
Carbone, 2009). Another hypothesis could be the influx of blood-derived DC that can
migrate to tissue anytime there is inflammation whether sterile or infectious. We have
previously shown that blood-derived DC constitutively express high level of E-and P-selctin
ligand leading to their ability for skin migration(Robert et al., 1999). Moreover It has been
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tpreviously shown(Eidsmo et al., 2009) in HSV skin infection model that blood-derived DC
can migrate to infected skin at a latter time by day 5. These newly recruited DC might serve
as new antigen presenting cells to continue T cell activation.
Another point of our observation is that antigen-specific CD8+ T cell migration to skin is
reduced in the absence of Lang+dDC. At day 7 post immunization, we found in the
Lang+DC depleted mice, reduced percentage of CD8+ T cells in infected skin when
compared to the WT group and LC depleted group. However, despite the late activation of
effector CD8+ T cells occurring in the absence of Lang+dDC, these CD8+ T cells still
expressed skin homing receptors when they undergo proliferation in the skin draining LN at
the same level as control groups. The absence of Lang+dDC delays the generation of a
specific effector T cell response but does not impair skin homing imprinting when CD8+ T
cells become activated. The defect of migration observed in our study results from a defect
of T cells proliferation but is not due to a defect of skin imprinting. These findings are
consistent with our previous results suggesting that homing-imprinting program can be
acquired by activated T cells circulating through the tissue-draining LN microenvironments
(stromal cells, tissue-specific DC) independent of antigen presentation (Liu et al., 2006).
A persistent question is the precise role of LC in the generation of immune response. LC
have long been accepted in the literature to be the most powerful DC subset for T cell
priming (Merad et al., 2008). This postulate has been challenged since the discovery of
Lang+dDC as a distinct DC subset from LC (Bursch et al., 2007; Poulin et al., 2007). Data
using LC- deficient mouse models indicated that LC mediate immune tolerance, especially
in contact hypersensitivity reactions or more generally are not required for the generation of
effector T cells response against a variety of antigens (Igyarto et al., 2009; Kaplan, 2010;
Kaplan et al., 2005; Zahner et al., 2011). Other recent data from human samples suggest that
LC function to induce proliferation of regulatory T cells, or Treg cells(Seneschal et al.,
2012). However, recent observations indicate that LC are capable to induce Th17 responses
especially against extracellular pathogens in a infection model(Igyarto et al., 2011).
However it is less clear that LC could induce cross-presentation. Our present data did not
show significant differences between the LC depleted groups and the WT groups in any of
the in vitro or in vivo assays we performed. We can conclude that LC are dispensable for
CD8+ T cell priming against VACV, compared to Lang+dDC. However, it is also notable
that eliminating the LC population did not enhance the activation and the proliferation of
CD8+ T cells, and we could not demonstrate in the VACV model any immunoregulatory
role of LC. These results may be due to technical issues: LC depleted mice group were i.p.
injected with DT 13 days before the beginning of the experiment. While epidermal LC
completely absent from skin after 13 days, the Lang+dDC population has partially but not
completely been restored in the dermis. However, the diminished number of Lang+dDC in
our Lang-DTR mice 13 days after DT injection could explain the absence of exaggerated
immune response in the LC-depleted mice group. Another hypothesis could be the
functional impairment that occurs during early repopulation of Lang+dDC, leading to the
reduction of their pro-inflammatory capacity as previously suggested (Kaplan, 2010). Our
study does not distinguish between these possibilities. Finally, our in vitro was extended in
vivo in an antigen specific tumor challenge model. While s.s.-immunized WT and LC
depleted mice controlled the progression of OVA expressing T cell lymphoma injected
intradermally, the depletion of Lang+DC led to eventual lymphoma progression and
mortality. However, tumor growth was still significantly delayed in these mice, suggesting a
role for Lang−DC and lymph node resident DC. In conclusion, our present data indicate that
of all skin resident DC subsets, Ln+dDC are critical for the generation of robust CD8+ T cell
immunity to infection after s.s. with VACV.
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tMETHODS
Mice, viruses, and viral infection
All animal work in compliance with the guidelines set out by the Center for Animal
Resources and Comparative Medicine at Harvard Medical School (HMS). Six-to eight
week-old female wt C57BL/6, Lang-DTR, Lang-EGFP and Thy1.1+ OT-I Rag1-/- mice
were bred in a biosafety level 1 facility at HMS. rVACV-ova were kind gifts from Dr.
Bernard Moss (National Institutes of Health, Bethesda, MD). The virus stocks were
expanded and titered in Hela cells and CV-1 cells (American Tissue Culture Company) by
standard procedures. Mice were infected with the virus by skin scarification (2×106 pfu in
5µl of PBS). For scarification, mice were anesthetized i.p. with 2, 2, 2 tribromoethanol
(250mg/kg, Sigma). 5µl of diluted virus was applied to tail skin 1 cm from the base of the
tail. The skin area was gently scratched 25 times with a 28 ½ G needle.
Chimeras, antibodies and Flow Cytometry
Directly conjugated mAbs Thy1.1-PerCP (OX7), CD8α-PECy7 (53-6.7), IFNγ-APC
(XMG1.2), MHC class II-Biotin (AF6-120.1), CD11b-APC (M1/70), CD19-PE (1D3),
PerCP streptavidin were purchased from BD Pharmingen. rmE-Selectin/Fc chimera and
rmP-Selectin/Fc chimera were purchased from R&D Systems. Data were acquired on 6-
color flow cytometer and analyzed.
Adoptive Transfer of OT-I Cells
Spleens and LNs were harvested from three-to four week-old Thy1.1+ OT-I Rag1-/-mice.
Red blood cells (RBC) were lysed and single-cell suspension was prepared. CD8+ T cells
were isolated with the mouse CD8α+ T cell isolation kit according to the manufacturer’s
protocol (Miltenyi Biotec). The purity of the isolated cells was >95% measured by flow
cytometry. Before CFSE staining, cells were washed twice with cold PBS and incubated at
10×106 cells/ml in PBS with 2 µM CFSE (Molecular Probes) at 37C for 3 min. Cells were
then washed twice with cold DMEM/10% FCS. 2× 106 OT-I cells were injected i.v. in
Thy1.2+ recipient mice.
In vivo depletion of LC or of Lang+ dDC
For systemic in vivo depletion of Lang+ dDC, Lang-DTR mice were injected i.p. with 1µg
DT (Sigma-Aldrich) using the specified timing of administration. For some in vivo
experiments mice were injected i.p. with 20ng/g DT.
Intracellular Staining
Ex vivo intracellular cytokine staining, cells were cultured at 37°C for 6h in complete
medium supplemented with 1.0 µg/ml of Monensin (GolgiStop BD Pharmingen), in either
the presence or the absence of OVA257–264 peptide at 1.0 µg/ml. Cells were then labeled for
surface epitopes and then were fixed and permeabilized using Cytofix/Cytoperm kit (BD
Biosciences) before staining for intracellular markers according to the manufacturer’s
instructions.
Detection of T cells in skin tissue
Skin samples were harvested from the base of the tails at different times after rVACV-ova
vaccinia challenge. Skin tail was incubated in HBSS containing 1mg/ml collagenase A and
40 µg/ml DNase I (Roche Diagnostics) at 37°C for 2 h. HBSS containing 2mM EDTA and
5% FCS was then added to stop the digestion. Single cell suspension was prepared by
passing cells through 70-micron cell strainers. Cells were then stained with appropriate
antibodies and analyzed by Flow Cytometry.
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To detect E-lig and P-lig expression, non specific binding to Fc receptors was blocked by
anti-mouse CD16/CD32. Cells then were incubated with 5µg/ml of rmCD62E/Fc chimera or
rmCD62P/Fc chimera in HBSS supplemented with 2mM calcium, 5% FCS and 1 mM
Hepes buffer at 4°C fro 30 mn. After washes, cells were incubated with APC anti-hFc-IgG
at 4°C for an additional 30 mib. HBSS buffer supplemented with 5 mM EDTA instead of
calcium was used as control.
Cytotoxicity Assay
OT-I CTL used as a positive control were generated as described previously. Briefly, OT-I
splenocytes (1×106/well) in 24-well plates containing 1 ml of RPMI 1640, 10%FCS and
Penicillin/streptomycin solution (CM), containing OVA257–264 (1nM), IL-4 (175 U/ml R&D
System), IL-2 (50 U/ml). After 3 days in culture, the cells were washed and re-cultured at
0.5×106 cells/well in 24-well plates containing 1 ml of CM without OVA257–264, but with
the same cytokines that were present during initial culture. After an additional 2 days in
culture, the cells were harvested and used as effector cells. Naïve OT-I were used as a
negative control. At day 5 post immunization with rVACV-ova, cells were isolated from
spleen and skin draining lymph nodes (LN). Single cell suspension was prepared by passing
cells through 70-micron cell strainers. RBC were lysed and then OT-I were isolated by using
CD90.1 microbeads isolation kit (Miltenyi Biotec) according to the manufacturer’s
instructions.
2×103 Target cells (EG7: an OVA gene transfected EL4 thymoma cell line ATCC) were
successively stained with PKH-26 (Sigma; final concentration 2.5×10−6 M) and then with
2µM CFSE as previously described. Target cells were then co-cultured with Effector Cells at
various T:E ratio (1:25, 1:50, 1:100, 1:150) during 4h in a 96-well U-bottom plates (Becton
Dickinson) at 37°C, 5% CO2. Then cells were fixed and analyzed by Flow Cytometry
within 24h for CFSE dilution.
Tumor challenge
EG7 cells were maintained in DMEM supplemented with 10% heat-inactivated FCS,
Penicillin/Streptomycin solution, and 400µg/ml G-418 (Invitrogen Life Technologies).
C57BL/6 or Lang-DTREGFP mice were intradermally challenged in the lower back with 5×
106 EG7 cells. The longest diameter (L) and the perpendicular diameter (W) of the local
tumor were measured with calipers at the indicated time points. Tumor volumes were
calculated using the formula Volume =L2× W / 2.
Statistics
The differences in the means between groups were compared using a one-tailed student’s
test. P ≤ 0.05 was considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. CD8+ T cells activation was delayed in the absence of Lang+dDC after tail s.s. with
rVACV-ova
CFSE-labeled naïve Thy1.1+ OT-I cells were transferred into Thy1.2+ B6 or in Thy1.2+
Lang-DTR mice. (a) Recipient Lang-DTR mice were treated with DT 13 days only (LC
depleted group) or 13 days, 1 day before rVV-ova immunization and then every 48h
(Lang+DC depleted group). WT C57BL/6 mice were also treated with DT as the Lang+DC
depleted group. Recipient mice were then infected with rVACV-ova by s.s. (b) Proliferation
of OT-I cells in ILN was analyzed at day 3, 5 and 7 by flow cytometry. Histograms were
gated on Thy1.1+CD8+ OT-I donor and are representative of 4 independent experiments.
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tFigure 2. Recruitment of OT-I cells to the infected skin site is less efficient in the absence of
Lang+dDC after s.s. with VACV
CFSE-labeled naïve Thy1.1+ OT-I cells were transferred into Thy1.2+ C57BL/6 or in
Thy1.2+ lang-DTR mice. Recipient lang-DTR mice were treated with DT 13 days only (LC
depleted group) or 13 days, 1 day before rVACV-ova immunization and then every 48h
(Lang+DC depleted group). WT C57BL/6 mice were also treated with DT as the Lang+DC
depleted group. 24h after OT-I transfer, recipient mice were infected with rVACV-ova by
s.s. OT-I cells were isolated from infected skin at various time points (day 3 and 7). (a)
Numbers in quadrant indicate percent of Thy1.1+ for one representative mouse. (b)
Percentage of Thy1.1+ cells in infected skin. The graph shows means +/− SD. Data are
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trepresentative of 3 independent experiments. (c) E- and P-lig expression was examined by
incubating cells from ILN with rmCD62E/Fc or rmCD62P/Fc chimera in HBSS buffer
containing 2 mM calcium at day 3 and 7. HBSS buffer supplemented with 5 mM EDTA was
used for the controls. Data are representative of 3 independent experiments. (d) Percentage
of E- and P-lig+ cells in the proliferating cells. The graph shows means +/− SD. Data are
representative of 3 independent experiments.
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tFigure 3. OT-I effector response is impaired in the absence of Lang+dDC after s.s. withrVACV-
ova
CFSE-labeled naïve Thy1.1+ OT-I cells were transferred into Thy1.2+ C57BL/6 or in
Thy1.2+ Lang-DTR mice. Recipient Lang-DTR mice were treated with DT 13 days before
immunization (LC depleted group), or 13 days, 1 day before immunization and then every
48h (Lang+DC depleted group). WT C57BL/6 mice were also treated as the Lang+DC
depleted group. Recipient mice were then s.s. immunized with rVACV-ova. (a) At day 3 and
7, cells from ILN and spleen were isolated and re-stimulated in vitro with OVA257–264
peptide for 6h and analyzed for intracellular interferon-γ (IFN-γ). Cells were gated on
Thy1.1+CD8+ OT-I cells. Numbers in quadrant indicate percent of cells. (b) Percentage of
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tIFNγ+ OT-I cells in ILN and spleen. The graph shows means +/− SD. Data are
representative of 3 independent experiments.
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tFigure 4. Lang+dDC are required to induce a strong specific cytotoxic activity in vitro
Naïve Thy1.1+ OT-I cells were transferred into Thy1.2+ C57BL/6 or in Thy1.2+ lang-DTR
mice. Recipient Lang-DTR mice were treated with DT 13 days only (LC depleted group) or
13 days, 1 day before rVACV-ova immunization and then every 48h (Lang+DC depleted
group). WT C57BL/6 mice were also treated with DT as the Lang+DC depleted group.
Recipient mice were then s.s. immunized with rVACV-ova. At day 5 post immunization,
spleen and skin draining lymph nodes were harvested and OT-I cells were isolated. Effector
OT-I were generated in vitro and used as positive control. Naïve OT-I cells were used as a
negative control. OT-I cells were then cultured with target cells (EG7) stained with PKH-26
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tand CFSE during 4h at various ratio in triplicate. Cytolysis was analyzed by the dilution of
CFSE on PKH-26+ cells using flow cytometry. Each data point represent means +/− SD.
Data are representative of 2 independent experiments.
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tFigure 5. Lang+dDC are required for efficient protection provided by s.s. with rVACV against
tumor challenge
Lang-DTR mice were treated with DT 13 days (LC depleted group) or 13 days, 1 day before
immunization and then every 72h (Lang+DC depleted group). C57BL/6 WT mice were
treated with DT as the Lang+DC depleted group. Mice were then s.s. immunized with
rVACV-ova. The same day mice were challenged with EG7 (5×106 cells/mouse)
intradermally, and monitored for tumor growth (a,b). Each data point represents the mean
tumor volume of different groups (n=8). Data is the pooled results of 2 independent
experiments.
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